Atomoxetine
Back to searchMolecule Structure
Scientific Name
Atomoxetine
Description of the Drug
Atomoxetine is a selective norepinephrine reuptake inhibitor (SNRI) used in the management of Attention Deficit Hyperactivity Disorder (ADHD).
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00289
http://www.drugbank.ca/drugs/DB00289
Brand Name(s)
Not Available
Company Owner(s)
Apotex Inc, Sun Pharma Global Inc, Sandoz Inc, Mylan Pharmaceuticals Inc A Viatris Co, Eli Lilly And Co, Aurobindo Pharma Ltd, Glenmark Pharmaceuticals Ltd, Dr Reddys Laboratories Ltd, Actavis Elizabeth Llc, Teva Pharmaceuticals Usa
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Norepinephrine transporter | SINGLE PROTEIN | INHIBITOR | CHEMBL222 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL34268 | ||
| PharmGKB | PA134688071 | ||
| Human Metabolome Database | HMDB0014434 | ||
| DrugBank | DB00289 | ||
| PubChem: Thomson Pharma | 14749997 | 15196878 | |
| PubChem | 54841 | ||
| LINCS | LSM-2452 | ||
| Nikkaji | J525.770K | ||
| BindingDB | 50366567 | ||
| EPA CompTox Dashboard | DTXSID9044297 | ||
| DrugCentral | 256 | ||
| Brenda | 80131 | ||
| ChemicalBook | CB3378328 | ||
| Guide to Pharmacology | 7118 | ||
| rxnorm | ATOMOXETINE HYDROCHLORIDE | STRATTERA | ATOMOXETINE |
| ChEBI | 127342 | ||
| ZINC | ZINC000001842633 |
